Business Description
Valneva SE
ISIN : FR0004056851
Compare
Compare
Traded in other countries / regions
VLA.France0OB3.UKVALN.USAAYJ.GermanyVLA.AustriaAYJ.Bulgaria IPO Date
2013-06-25Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.93 | |||||
| Debt-to-EBITDA | 9.51 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.07 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EBITDA Growth Rate | 5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year Book Growth Rate | 2.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 20.53 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.19 | |||||
| 9-Day RSI | 2.84 | |||||
| 14-Day RSI | 8.27 | |||||
| 3-1 Month Momentum % | -21.63 | |||||
| 6-1 Month Momentum % | -33.94 | |||||
| 12-1 Month Momentum % | -49.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | |||||
| Quick Ratio | 2.25 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 178.24 | |||||
| Days Sales Outstanding | 80.19 | |||||
| Days Payable | 147.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.2 | |||||
| Shareholder Yield % | -15.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.58 | |||||
| Operating Margin % | -51.44 | |||||
| Net Margin % | -4.68 | |||||
| FCF Margin % | -106.16 | |||||
| ROE % | -4.32 | |||||
| ROA % | -1.5 | |||||
| ROIC % | -27.77 | |||||
| 3-Year ROIIC % | -99.49 | |||||
| ROC (Joel Greenblatt) % | 10.95 | |||||
| ROCE % | 6.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 100.19 | |||||
| PS Ratio | 1.69 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.63 | |||||
| EV-to-EBIT | 16.43 | |||||
| EV-to-EBITDA | 16.43 | |||||
| EV-to-Revenue | 2.19 | |||||
| EV-to-Forward-Revenue | 1.77 | |||||
| EV-to-FCF | -2.06 | |||||
| Price-to-GF-Value | 0.57 | |||||
| Price-to-Median-PS-Value | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 66 | |||||
| Earnings Yield (Greenblatt) % | 6.09 | |||||
| FCF Yield % | -55.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INRLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valneva SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 173.119 | ||
| EPS (TTM) ($) | -0.066 | ||
| Beta | 1.72 | ||
| 3-Year Sharpe Ratio | -1.03 | ||
| 3-Year Sortino Ratio | -1.26 | ||
| Volatility % | 53.98 | ||
| 14-Day RSI | 8.27 | ||
| 14-Day ATR ($) | 0.035637 | ||
| 20-Day SMA ($) | 2.2424 | ||
| 12-1 Month Momentum % | -49.82 | ||
| 52-Week Range ($) | 2.08 - 5.4 | ||
| Shares Outstanding (Mil) | 162.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valneva SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valneva SE Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valneva SE Frequently Asked Questions
What is Valneva SE(INRLF)'s stock price today?
The current price of INRLF is $1.98. The 52 week high of INRLF is $5.40 and 52 week low is $2.08.
When is next earnings date of Valneva SE(INRLF)?
The next earnings date of Valneva SE(INRLF) is 2025-03-20.
Does Valneva SE(INRLF) pay dividends? If so, how much?
Valneva SE(INRLF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers